What is Alnylam Pharmaceuticals's capex?

Alnylam Pharmaceuticals (ALNY) reported capex of $21.83M in Q1 2026.

How has Alnylam Pharmaceuticals's capex changed year-over-year?

Alnylam Pharmaceuticals's capex increased by 143.4% year-over-year, from $8.97M to $21.83M.

What is the long-term trend for Alnylam Pharmaceuticals's capex?

Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's capex has grown at a -6.4% compound annual growth rate (CAGR), from $76.37M to $58.7M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Alnylam Pharmaceuticals ALNY CapEx

CapEx at other companies

Ionis PharmaceuticalsIONS

$21.76M+73.0%

Arrowhead ResearchARWR

$2.57M-51.6%

PTC TherapeuticsPTCT

$1.2M-30.6%

Assembly BiosciencesASMB

$19K—

Wave Life SciencesWVE

$438K+165%

Intellia TherapeuticsNTLA

$79K-89.3%

Other financials

Income statement

See full

Revenue$1.2B+96.4%

Gross profit$959.7M+83.1%

Operating income$268.6M+1,386%

Net income$206.0M+1,229%

EPS (diluted)$1.51+1,179%

Balance sheet

See full

Cash & equivalents$1.7B+67.5%

Total debt$263.7M-4.5%

Total equity$1.1B+152%

Total assets$5.1B+21.7%

Cash flow

See full

Operating cash flow$70.5M+159%

Free cash flow$48.7M+138%

Valuation

See full

Market cap$40.19B+0.6%

Enterprise value$38.74B-0.8%

P/E80×—

P/S9.4×-6.8×

Profitability

See full

Gross margin81%-5.3pp

Operating margin17.5%+14.4pp

Net margin11.7%+8.0pp

FCF margin15%+12.7pp

Returns & leverage

See full

Return on equity66.9%—

Debt / equity0.2×-0.4×

Current ratio3.1×+0.1×

Where this comes from

Reported directly by Alnylam Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's capex?: Alnylam Pharmaceuticals (ALNY) reported capex of $21.83M in Q1 2026.
How has Alnylam Pharmaceuticals's capex changed year-over-year?: Alnylam Pharmaceuticals's capex increased by 143.4% year-over-year, from $8.97M to $21.83M.
What is the long-term trend for Alnylam Pharmaceuticals's capex?: Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's capex has grown at a -6.4% compound annual growth rate (CAGR), from $76.37M to $58.7M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.